Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
Open Access
- 1 April 2013
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (4), 7193-7230
- https://doi.org/10.3390/ijms14047193
Abstract
The formyl peptide receptor 2 (FPR2) is a remarkably versatile transmembrane protein belonging to the G-protein coupled receptor (GPCR) family. FPR2 is activated by an array of ligands, which include structurally unrelated lipids and peptide/proteins agonists, resulting in different intracellular responses in a ligand-specific fashion. In addition to the anti-inflammatory lipid, lipoxin A4, several other endogenous agonists also bind FPR2, including serum amyloid A, glucocorticoid-induced annexin 1, urokinase and its receptor, suggesting that the activation of FPR2 may result in potent pro- or anti-inflammatory responses. Other endogenous ligands, also present in biological samples, include resolvins, amyloidogenic proteins, such as beta amyloid (Aβ)-42 and prion protein (Prp)106–126, the neuroprotective peptide, humanin, antibacterial peptides, annexin 1-derived peptides, chemokine variants, the neuropeptides, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP)-27, and mitochondrial peptides. Upon activation, intracellular domains of FPR2 mediate signaling to G-proteins, which trigger several agonist-dependent signal transduction pathways, including activation of phospholipase C (PLC), protein kinase C (PKC) isoforms, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, the mitogen-activated protein kinase (MAPK) pathway, p38MAPK, as well as the phosphorylation of cytosolic tyrosine kinases, tyrosine kinase receptor transactivation, phosphorylation and nuclear translocation of regulatory transcriptional factors, release of calcium and production of oxidants. FPR2 is an attractive therapeutic target, because of its involvement in a range of normal physiological processes and pathological diseases. Here, we review and discuss the most significant findings on the intracellular pathways and on the cross-communication between FPR2 and tyrosine kinase receptors triggered by different FPR2 agonists.Keywords
This publication has 155 references indexed in Scilit:
- Annexin A1 Interaction with the FPR2/ALX ReceptorJournal of Biological Chemistry, 2012
- Serum amyloid A opposes lipoxin A4to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary diseaseProceedings of the National Academy of Sciences, 2012
- Resolvins and Protectins in Inflammation ResolutionChemical Reviews, 2011
- Resolvins: Natural agonists for resolution of pulmonary inflammationProgress in Lipid Research, 2011
- Human Formyl Peptide Receptor 2 Senses Highly Pathogenic Staphylococcus aureusCell Host & Microbe, 2010
- The Annexin I Sequence Gln9-Ala10-Trp11-Phe12 Is a Core Structure for Interaction with the Formyl Peptide Receptor 1Journal of Biological Chemistry, 2010
- 6-Methyl-2,4-Disubstituted Pyridazin-3(2H)-ones: A Novel Class of Small-Molecule Agonists for Formyl Peptide ReceptorsJournal of Medicinal Chemistry, 2009
- The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6The Journal of Experimental Medicine, 2008
- Uteroglobin suppresses allergen‐induced TH2 differentiation by down‐regulating the expression of serum amyloid A and SOCS‐3 genesFEBS Letters, 2006